Cargando…
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also signif...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827636/ https://www.ncbi.nlm.nih.gov/pubmed/34613865 http://dx.doi.org/10.1080/21645515.2021.1976580 |
_version_ | 1784647674846248960 |
---|---|
author | Gunn, Bronwyn M. Bai, Shuangyi |
author_facet | Gunn, Bronwyn M. Bai, Shuangyi |
author_sort | Gunn, Bronwyn M. |
collection | PubMed |
description | Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also significantly contributes to antiviral protection. Recruitment of innate immune cells such as natural killer cells, neutrophils, monocytes, macrophages, dendritic cells and the complement system by antibodies can lead to direct restriction of viral infection as well as promoting long-term antiviral immunity. Monoclonal antibody therapeutics against viruses are increasingly incorporating Fc-enhancing features to take advantage of the Fc domain, uncovering a surprising breadth of mechanisms through which antibodies can control viral infection. Here, we review the recent advances in our understanding of antibody-mediated innate immune effector functions in protection from viral infection and review the current approaches and challenges to effectively leverage innate immune cells via antibodies. |
format | Online Article Text |
id | pubmed-8827636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88276362022-02-10 Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection Gunn, Bronwyn M. Bai, Shuangyi Hum Vaccin Immunother Reviews Antibodies can provide antiviral protection through neutralization and recruitment of innate effector functions through the Fc domain. While neutralization has long been appreciated for its role in antibody-mediated protection, a growing body of work indicates that the antibody Fc domain also significantly contributes to antiviral protection. Recruitment of innate immune cells such as natural killer cells, neutrophils, monocytes, macrophages, dendritic cells and the complement system by antibodies can lead to direct restriction of viral infection as well as promoting long-term antiviral immunity. Monoclonal antibody therapeutics against viruses are increasingly incorporating Fc-enhancing features to take advantage of the Fc domain, uncovering a surprising breadth of mechanisms through which antibodies can control viral infection. Here, we review the recent advances in our understanding of antibody-mediated innate immune effector functions in protection from viral infection and review the current approaches and challenges to effectively leverage innate immune cells via antibodies. Taylor & Francis 2021-10-06 /pmc/articles/PMC8827636/ /pubmed/34613865 http://dx.doi.org/10.1080/21645515.2021.1976580 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Reviews Gunn, Bronwyn M. Bai, Shuangyi Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title | Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title_full | Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title_fullStr | Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title_full_unstemmed | Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title_short | Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection |
title_sort | building a better antibody through the fc: advances and challenges in harnessing antibody fc effector functions for antiviral protection |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827636/ https://www.ncbi.nlm.nih.gov/pubmed/34613865 http://dx.doi.org/10.1080/21645515.2021.1976580 |
work_keys_str_mv | AT gunnbronwynm buildingabetterantibodythroughthefcadvancesandchallengesinharnessingantibodyfceffectorfunctionsforantiviralprotection AT baishuangyi buildingabetterantibodythroughthefcadvancesandchallengesinharnessingantibodyfceffectorfunctionsforantiviralprotection |